Ranjit Rai
Ranjit Rai has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Andreia Pinto
Royal Brompton Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
3 shared publications - Thomas Burgoyne
University College London
3 shared publications - Amelia Shoemark
Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK
2 shared publications - Claire Hogg
Paediatric Respiratory Medicine, Primary Ciliary Dyskinesia Centre, Royal Brompton & Harefield NHS Trust, London SW3 6NP, UK
2 shared publications - Francisco Parra
Instituto Universitario de Biotecnología de Asturias (IUBA), Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, 33006 Oviedo, Spain
2 shared publications A Dicker
University of Dundee, Dundee, UK
1 shared publication
Latest Publications
- 1 November 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (11) , 2043-2052
Noncoding DNA Variants Increase the Genetic Diagnostic Yield in Primary Ciliary Dyskinesia
Rationale: Primary ciliary dyskinesia (PCD) is a rare respiratory disorder of motile cilia caused by pathogenic variants in >50 known genes. Genetic testing routinely examines the coding regions of these genes, and biallelic pathogenic variants are reported in as many as 70% of patients. Many patients remain with an incomplete or no genetic diagnosis. Objectives: To retrospectively analyze the diagnostic yield in 496 patients referred for genetic testing and the increase in yield by investigating pathogenic DNA variants in the noncoding regions of PCD genes in 42 patients with an incomplete genetic diagnosis. Methods: End-to-end next-generation gene sequencing including coding and noncoding regions of 17 PCD genes was performed, following routine genetic diagnosis of a panel of more than 46 genes. Intronic variants were prioritized for pathogenicity using in silico tools to predict splice effects that were subsequently confirmed in RNA extracted from nasal epithelium. Measurements and Main Results: 232 of 496 patients (46.8%) had a complete genetic diagnosis of PCD after stringent variant assessment during routine genetic testing. Eighty-six patients (17.3%) had an incomplete genetic diagnosis, 42 of whom had end-to-end gene sequencing. Novel, potentially pathogenic, noncoding variants were identified in 16 of 42 patients (38.1%). Three recurrent deep-intronic variants were found. Conclusions: Diagnostic yield for PCD is increased by end-to-end gene sequencing. Noncoding variants that affect splicing are recurrent and are an important source of pathogenic genomic variation in patients with PCD. This work illustrates the potential clinical utility of end-to-end gene or genome sequencing for PCD.
- 1 November 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (11) , 2043-2052
Noncoding DNA Variants Increase the Genetic Diagnostic Yield in Primary Ciliary Dyskinesia
Rationale: Primary ciliary dyskinesia (PCD) is a rare respiratory disorder of motile cilia caused by pathogenic variants in >50 known genes. Genetic testing routinely examines the coding regions of these genes, and biallelic pathogenic variants are reported in as many as 70% of patients. Many patients remain with an incomplete or no genetic diagnosis. Objectives: To retrospectively analyze the diagnostic yield in 496 patients referred for genetic testing and the increase in yield by investigating pathogenic DNA variants in the noncoding regions of PCD genes in 42 patients with an incomplete genetic diagnosis. Methods: End-to-end next-generation gene sequencing including coding and noncoding regions of 17 PCD genes was performed, following routine genetic diagnosis of a panel of more than 46 genes. Intronic variants were prioritized for pathogenicity using in silico tools to predict splice effects that were subsequently confirmed in RNA extracted from nasal epithelium. Measurements and Main Results: 232 of 496 patients (46.8%) had a complete genetic diagnosis of PCD after stringent variant assessment during routine genetic testing. Eighty-six patients (17.3%) had an incomplete genetic diagnosis, 42 of whom had end-to-end gene sequencing. Novel, potentially pathogenic, noncoding variants were identified in 16 of 42 patients (38.1%). Three recurrent deep-intronic variants were found. Conclusions: Diagnostic yield for PCD is increased by end-to-end gene sequencing. Noncoding variants that affect splicing are recurrent and are an important source of pathogenic genomic variation in patients with PCD. This work illustrates the potential clinical utility of end-to-end gene or genome sequencing for PCD.
- Open Access
- 23 July 2025
- Published by Wiley in Journal of Anatomy
- Vol. 248 (1) , 108-125
Anatomy of a bioengineered human pigmented skin equivalent to provide fundamental insights into skin tone melanin dynamics
Full‐thickness skin equivalents provide a platform for preclinical screening, streamlining the clinical trial process and reducing the need for animal testing while also providing a tool capable of fundamental insights into skin biology. Understanding the specific role of melanin dynamics across various skin tones is essential not only to better understand its function in photoprotection but is also better representative of a diverse population. Although pigmented skin equivalents (PSEs) have been reported in the literature, they rarely recapitulate the structural location of melanin within native keratinocytes, which is pivotal to its photoprotective role. This is due in part to the reliance of existing technologies on exogenous or animal‐derived extracellular matrix (ECM) constituents or the complete lack of a dermal compartment. In this study, we describe the development of novel PSEs representative of skin pigmentation phenotypes in vitro, which comprise fibroblast‐secreted endogenous ECM and a differentiated, well‐organised epidermis that resembles diverse skin tones. We demonstrate that these skin tones display morphological differences at a gross, histological and ultrastructural level. We then utilised the system to provide fundamental insights into the processes of melanogenesis, melanin transfer from melanocytes to keratinocytes, supranuclear cap formation and melanosome organisation within the epidermis. Quantification of melanosome dynamics allowed for comparison to native tissue and among skin tones, providing a detailed comparison among experimental conditions. This innovative technology enables a wide range of applications, such as studying pigmentation mechanisms in skin responses to external stimuli, disease modelling and drug testing involving the interactions between the epidermis and dermis.
- 23 July 2025
- Published by Wiley in Journal of Anatomy
- Vol. 248 (1) , 108-125
Open AccessAnatomy of a bioengineered human pigmented skin equivalent to provide fundamental insights into skin tone melanin dynamics
Full‐thickness skin equivalents provide a platform for preclinical screening, streamlining the clinical trial process and reducing the need for animal testing while also providing a tool capable of fundamental insights into skin biology. Understanding the specific role of melanin dynamics across various skin tones is essential not only to better understand its function in photoprotection but is also better representative of a diverse population. Although pigmented skin equivalents (PSEs) have been reported in the literature, they rarely recapitulate the structural location of melanin within native keratinocytes, which is pivotal to its photoprotective role. This is due in part to the reliance of existing technologies on exogenous or animal‐derived extracellular matrix (ECM) constituents or the complete lack of a dermal compartment. In this study, we describe the development of novel PSEs representative of skin pigmentation phenotypes in vitro, which comprise fibroblast‐secreted endogenous ECM and a differentiated, well‐organised epidermis that resembles diverse skin tones. We demonstrate that these skin tones display morphological differences at a gross, histological and ultrastructural level. We then utilised the system to provide fundamental insights into the processes of melanogenesis, melanin transfer from melanocytes to keratinocytes, supranuclear cap formation and melanosome organisation within the epidermis. Quantification of melanosome dynamics allowed for comparison to native tissue and among skin tones, providing a detailed comparison among experimental conditions. This innovative technology enables a wide range of applications, such as studying pigmentation mechanisms in skin responses to external stimuli, disease modelling and drug testing involving the interactions between the epidermis and dermis.
- Open Access
S55 Persistent changes to the nasal ciliated epithelium following SARS-CoV2 infection: a longitudinal cohort analysis from FOLLOW-COVID
Background SARS-CoV2 binds to the respiratory epithelium. Little is known about the recovery and regeneration of the epithelium following COVID-19. Poor recovery could leave individuals at risk of secondary bacterial infection and persistent symptoms. The aim of this study was to assess epithelial recovery following SARS-CoV2 infection across a range of acute illness severities. Methods 41 people were recruited at 3–12 months post PCR confirmed SARS-CoV2 infection. The respiratory epithelium was sampled by brushing the nasal inferior turbinate. Ciliary function was assessed by high-speed video microscopy and ultrastructure was assessed by electron microscopy. A subset of patients had repeat nasal brushing 3–5 months following their first visit. Demographics, severity of infection and longitudinal symptoms were recorded for comparison. Results were compared to healthy controls and historical controls recruited prior to the pandemic. Results Post-COVID epithelium was friable and most samples contained detached single cells and blood. Epithelial disruption score was 3.0 ±0.6 compared to 2.4 ±0.6 for controls (pConclusion Epithelial disruption and defects in epithelial regeneration persist for up to 1 year post infection with SARS-CoV-2, irrespective of initial illness severity. Persisting inflammation, or a failure of repair, are possible pathological processes for further exploration.
Open AccessS55 Persistent changes to the nasal ciliated epithelium following SARS-CoV2 infection: a longitudinal cohort analysis from FOLLOW-COVID
Background SARS-CoV2 binds to the respiratory epithelium. Little is known about the recovery and regeneration of the epithelium following COVID-19. Poor recovery could leave individuals at risk of secondary bacterial infection and persistent symptoms. The aim of this study was to assess epithelial recovery following SARS-CoV2 infection across a range of acute illness severities. Methods 41 people were recruited at 3–12 months post PCR confirmed SARS-CoV2 infection. The respiratory epithelium was sampled by brushing the nasal inferior turbinate. Ciliary function was assessed by high-speed video microscopy and ultrastructure was assessed by electron microscopy. A subset of patients had repeat nasal brushing 3–5 months following their first visit. Demographics, severity of infection and longitudinal symptoms were recorded for comparison. Results were compared to healthy controls and historical controls recruited prior to the pandemic. Results Post-COVID epithelium was friable and most samples contained detached single cells and blood. Epithelial disruption score was 3.0 ±0.6 compared to 2.4 ±0.6 for controls (pConclusion Epithelial disruption and defects in epithelial regeneration persist for up to 1 year post infection with SARS-CoV-2, irrespective of initial illness severity. Persisting inflammation, or a failure of repair, are possible pathological processes for further exploration.
- Open Access
- 9 June 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (6) , 1063
UA-Zero as a Uranyl Acetate Replacement When Diagnosing Primary Ciliary Dyskinesia by Transmission Electron Microscopy
Primary ciliary dyskinesia (PCD) is a disorder affecting motile cilia. An early accurate diagnosis helps prevent lung damage and preserve lung function. To make a diagnostic assessment, one of the commonly used methods that allows for the examination of ciliary ultrastructure is transmission electron microscopy (TEM). This allows for a quantitative assessment of ciliary components to identify defects associated with PCD. Heavy metal staining is required to provide a contrast when imaging cilia in the TEM. One of the most commonly used stains is uranyl acetate (UA). UA can be applied to cellular material before embedding (en bloc), or to ultrathin sections of embedded samples (grid staining). UA is radioactive and, due to growing safety concerns and restrictions by government bodies, universities and hospitals, it is essential to find a suitable alternative. We show UA-zero (UAZ), when used en bloc, provides a high contrast and is a suitable replacement for UA. PCD diagnostic experts, having reviewed ciliary cross-sections stained with UAZ en bloc, are confident that the staining and PCD defects are readily detectable similar to samples that have been stained with UA.
- 9 June 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (6) , 1063
Open AccessUA-Zero as a Uranyl Acetate Replacement When Diagnosing Primary Ciliary Dyskinesia by Transmission Electron Microscopy
Primary ciliary dyskinesia (PCD) is a disorder affecting motile cilia. An early accurate diagnosis helps prevent lung damage and preserve lung function. To make a diagnostic assessment, one of the commonly used methods that allows for the examination of ciliary ultrastructure is transmission electron microscopy (TEM). This allows for a quantitative assessment of ciliary components to identify defects associated with PCD. Heavy metal staining is required to provide a contrast when imaging cilia in the TEM. One of the most commonly used stains is uranyl acetate (UA). UA can be applied to cellular material before embedding (en bloc), or to ultrathin sections of embedded samples (grid staining). UA is radioactive and, due to growing safety concerns and restrictions by government bodies, universities and hospitals, it is essential to find a suitable alternative. We show UA-zero (UAZ), when used en bloc, provides a high contrast and is a suitable replacement for UA. PCD diagnostic experts, having reviewed ciliary cross-sections stained with UAZ en bloc, are confident that the staining and PCD defects are readily detectable similar to samples that have been stained with UA.
- Open Access
Detection of Recombinant Hare Myxoma Virus in Wild Rabbits (Oryctolagus cuniculus algirus)
In late 2018, an epidemic myxomatosis outbreak emerged on the Iberian Peninsula leading to high mortality in Iberian hare populations. A recombinant Myxoma virus (strains MYXV-Tol and ha-MYXV) was rapidly identified, harbouring a 2.8 kbp insertion containing evolved duplicates of M060L, M061L, M064L, and M065L genes from myxoma virus (MYXV) or other Poxviruses. Since 2017, 1616 rabbits and 125 hares were tested by a qPCR directed to M000.5L/R gene, conserved in MYXV and MYXV-Tol/ha-MYXV strains. A subset of the positive samples (20%) from both species was tested for the insert with MYXV being detected in rabbits and the recombinant MYXV in hares. Recently, three wild rabbits were found dead South of mainland Portugal, showing skin oedema and pulmonary lesions that tested positive for the 2.8 kbp insert. Sequencing analysis showed 100% similarity with the insert sequences described in Iberian hares from Spain. Viral particles were observed in the lungs and eyelids of rabbits by electron microscopy, and isolation in RK13 cells attested virus infectivity. Despite that the analysis of complete genomes may predict the recombinant MYXV strains’ ability to infect rabbit, routine analyses showed species segregation for the circulation of MYXV and recombinant MYXV in wild rabbit and in Iberian hares, respectively. This study demonstrates, however, that recombinant MYXV can effectively infect and cause myxomatosis in wild rabbits and domestic rabbits, raising serious concerns for the future of the Iberian wild leporids while emphasises the need for the continuous monitoring of MYXV and recombinant MYXV in both species.
Open AccessDetection of Recombinant Hare Myxoma Virus in Wild Rabbits (Oryctolagus cuniculus algirus)
In late 2018, an epidemic myxomatosis outbreak emerged on the Iberian Peninsula leading to high mortality in Iberian hare populations. A recombinant Myxoma virus (strains MYXV-Tol and ha-MYXV) was rapidly identified, harbouring a 2.8 kbp insertion containing evolved duplicates of M060L, M061L, M064L, and M065L genes from myxoma virus (MYXV) or other Poxviruses. Since 2017, 1616 rabbits and 125 hares were tested by a qPCR directed to M000.5L/R gene, conserved in MYXV and MYXV-Tol/ha-MYXV strains. A subset of the positive samples (20%) from both species was tested for the insert with MYXV being detected in rabbits and the recombinant MYXV in hares. Recently, three wild rabbits were found dead South of mainland Portugal, showing skin oedema and pulmonary lesions that tested positive for the 2.8 kbp insert. Sequencing analysis showed 100% similarity with the insert sequences described in Iberian hares from Spain. Viral particles were observed in the lungs and eyelids of rabbits by electron microscopy, and isolation in RK13 cells attested virus infectivity. Despite that the analysis of complete genomes may predict the recombinant MYXV strains’ ability to infect rabbit, routine analyses showed species segregation for the circulation of MYXV and recombinant MYXV in wild rabbit and in Iberian hares, respectively. This study demonstrates, however, that recombinant MYXV can effectively infect and cause myxomatosis in wild rabbits and domestic rabbits, raising serious concerns for the future of the Iberian wild leporids while emphasises the need for the continuous monitoring of MYXV and recombinant MYXV in both species.
- Open Access
- 11 September 2020
- Published by MDPI AG in Preprints.org
Detection of Recombinant Hare Myxoma Virus in Wild Rabbits (Oryctolagus cuniculus algirus)
In late 2018, an epidemic myxomatosis outbreak emerged on the Iberian Peninsula leading to high mortality in Iberian hare populations. Soon, a recombinant virus (MYXV-Tol or ha-MYXV) was identified, harboring a 2.8 kb insertion containing evolved duplicates of M060L, M061L, M064L, and M065L from MYXV. Since 2017, 1616 rabbits and 82 hares were tested by a qPCR directed to M000.5L/R gene, conserved in MYXV and MYXV-Tol/ ha-MYXV strains. A subset (20%) of the positive samples was tested for the insert with MYXV being detected in rabbits and recombinant MYXV in hares. Recently, two wild rabbits found dead in South Portugal, showing skin oedema and pulmonary lesions tested positive for the 2.8 Kb insert. Sequencing showed 100% similarity with the insert sequences described in Iberian hares from Spain. Viral particles were observed in the lungs of both rabbits by electron microscopy, and isolation in RK13 cells showed virus infectivity. Despite the analysis of recombinant MYXV genomes may predict its ability to infect rabbit, routine analyses showed species segregation for the circulation of MYXV and recombinant MYXV in wild rabbit and in Iberian hares, respectively. This study demonstrates, however, that recombinant MYXV can effectively infect and cause myxomatosis in wild rabbits and domestic rabbits, which raises serious concerns for the future of the Iberian wild leporids and emphasizes the need to continue monitoring MYXV and recombinant MYXV in both species.
- 11 September 2020
- Published by MDPI AG in Preprints.org
Open AccessDetection of Recombinant Hare Myxoma Virus in Wild Rabbits (Oryctolagus cuniculus algirus)
In late 2018, an epidemic myxomatosis outbreak emerged on the Iberian Peninsula leading to high mortality in Iberian hare populations. Soon, a recombinant virus (MYXV-Tol or ha-MYXV) was identified, harboring a 2.8 kb insertion containing evolved duplicates of M060L, M061L, M064L, and M065L from MYXV. Since 2017, 1616 rabbits and 82 hares were tested by a qPCR directed to M000.5L/R gene, conserved in MYXV and MYXV-Tol/ ha-MYXV strains. A subset (20%) of the positive samples was tested for the insert with MYXV being detected in rabbits and recombinant MYXV in hares. Recently, two wild rabbits found dead in South Portugal, showing skin oedema and pulmonary lesions tested positive for the 2.8 Kb insert. Sequencing showed 100% similarity with the insert sequences described in Iberian hares from Spain. Viral particles were observed in the lungs of both rabbits by electron microscopy, and isolation in RK13 cells showed virus infectivity. Despite the analysis of recombinant MYXV genomes may predict its ability to infect rabbit, routine analyses showed species segregation for the circulation of MYXV and recombinant MYXV in wild rabbit and in Iberian hares, respectively. This study demonstrates, however, that recombinant MYXV can effectively infect and cause myxomatosis in wild rabbits and domestic rabbits, which raises serious concerns for the future of the Iberian wild leporids and emphasizes the need to continue monitoring MYXV and recombinant MYXV in both species.
- Open Access
- 28 July 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (8) , 524
Ciliary Feature Counter: A program for the Quantitative Assessment of Cilia to Diagnose Primary Ciliary Dyskinesia
Primary ciliary dyskinesia (PCD) is a disorder that affects motile cilia in the airway that are required for the removal of mucus, debris, and pathogens. It is important to diagnose PCD in early childhood to preserve lung function. The confirmation of a diagnosis relies on the assessment of ciliary ultrastructure by transmission electron microscopy (TEM). TEM involves the quantitative assessment of the ciliary ultrastructure to identify PCD defects as well as abnormalities resulting from infection. Many specialist diagnostic centres still rely on physical counters to tally results and paper notes to summarise findings before transferring the results to computer databases/records. To speed up the diagnostic data collection and increase the protection of patient information, we have developed digital ciliary feature counters that conform to the PCD reporting international consensus guideline. These counters can be used on a computer or tablet, and automatically generate notes regarding sample observations. We show that the digital counters are easy to use and can generate TEM diagnostic reports that will be useful for many PCD diagnostic centres.
- 28 July 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (8) , 524
Open AccessCiliary Feature Counter: A program for the Quantitative Assessment of Cilia to Diagnose Primary Ciliary Dyskinesia
Primary ciliary dyskinesia (PCD) is a disorder that affects motile cilia in the airway that are required for the removal of mucus, debris, and pathogens. It is important to diagnose PCD in early childhood to preserve lung function. The confirmation of a diagnosis relies on the assessment of ciliary ultrastructure by transmission electron microscopy (TEM). TEM involves the quantitative assessment of the ciliary ultrastructure to identify PCD defects as well as abnormalities resulting from infection. Many specialist diagnostic centres still rely on physical counters to tally results and paper notes to summarise findings before transferring the results to computer databases/records. To speed up the diagnostic data collection and increase the protection of patient information, we have developed digital ciliary feature counters that conform to the PCD reporting international consensus guideline. These counters can be used on a computer or tablet, and automatically generate notes regarding sample observations. We show that the digital counters are easy to use and can generate TEM diagnostic reports that will be useful for many PCD diagnostic centres.